Dyslipemia
Conditions
Interventions
Experimental group:Panax notoginseng powder, orally, 3g/ time, twice/day
Combined use of placebo (Xuezhikang capsule simulator)
Control group:Xuezhikang capsule, orally, 0.6g/ time, twice/day
Combined with placebo (panax notoginseng powder simulator)
Sponsors
Guang 'anmen Hospital, China Academy of Chinese Medical Sciences
Eligibility
Sex/Gender
All
Age
30 Years to 70 Years
Inclusion criteria
Inclusion criteria: (1) Meet the diagnostic criteria for hyperlipidemia; (2) Age 30 ~ 70 years old; (3) TCM syndrome differentiation for phlegm and blood stasis interjunction; (4) Voluntary signing of informed consent.
Exclusion criteria
Exclusion criteria: (1) Secondary hyperlipidemia; (2) Taking drugs that affect lipid metabolism; (3) Patients with serious primary diseases of the heart, cerebrovascular and hematopoietic systems; (4) Severe hypertension, type 1 diabetes, type 2 diabetes (after hypoglycemic drug treatment, fasting blood glucose is still = 11.0mmol /L); (5) Abnormal liver and kidney function. Alanine aminotransferase (ALT) and/or aspartate aminotransferase (AST)= 1.5 times the upper limit of reference value, creatinine (Cr) > the upper limit of reference value; (6) People who are allergic to the known ingredients of the drugs used in this study and are allergic to them; (7) Malignant tumors, chronic alcoholism, drug dependence or mental illness; (8) Pregnancy, lactation or recent family planning; (9) Those who are judged by the investigator to be unfit to participate in clinical trials; (10) Participants who have participated in or are participating in other clinical trials within the last 3 months; (11) Poor compliance, withdrawal in the middle, serious organ injury, acute critical illness and infectious diseases; (12) Those found not to meet the inclusion criteria after inclusion; (13) Those who did not use any experimental drug for various reasons after inclusion
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Low density lipoprotein cholesterol; | — |
Secondary
| Measure | Time frame |
|---|---|
| Total cholesterol;Triglyceride;High density lipoprotein; | — |
Countries
China
Contacts
Public ContactWangjie
Guang 'anmen Hospital, China Academy of Chinese Medical Sciences
Outcome results
None listed